HSPA5 and cancer: Small-molecule agents that interfere with the synthesis, stability, or activity of GRP78 have the advantage that they can simultaneously shut down multiple progrowth and prosurvival pathways mediated by GRP78 in all cellular compartments, which will be difficult for cancer cells to overcome during the treatment period.